Regensburg, November 13, 2008 - GENEART AG, global leader in gene synthesis and specialist in the field of Synthetic Biology, increased its net sales by more than 30 % from EUR 9.0M to EUR 11.7M over the first nine months compared to the previous year's reference period. The operating result (EBIT) reached EUR 1.4M and hence, the level of the prior year. Thereby GENEART confirms its preliminary results published recently.
